Literature DB >> 16417247

Unilamellar liposomes with enhanced boron content.

Tiejun Li1, Julie Hamdi, M Frederick Hawthorne.   

Abstract

A new type of boron-rich, DSPC-free, unilamellar liposomes was formed using the novel dual-chain, ionic, nido-carborane lipid, K[nido-7-(C16H33OCH2)2CHOCH2-7,8-C2B9H11] (DAC-16), and cholesterol for encapsulation of an aqueous buffer core. Since DSPC was not necessary for the formation of stable DAC-16 liposomes, the boron concentration of these vesicles was increased dramatically to approximately 8.8 wt % in the dry lipid; these liposomes had a high bilayer boron incorporation efficiency of 98%. DSPC-free liposomes exhibited a size distribution pattern of 40-60 nm, which was in the range normally associated with selective tumor uptake. This size distribution was maintained throughout storage at room temperature for several months. Additionally, optimized liposome formulations incorporating DAC-16, DSPC, and cholesterol were identified having stable size distribution patterns after storage for more than two months at a variety of temperatures. Although animal studies indicate that DAC-16 liposomes are toxic, this new ionic nido-carborane lipid allows the formation of liposomes of high boron content for in vitro applications that require the delivery of large amounts of boron.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16417247     DOI: 10.1021/bc0501350

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  12 in total

1.  Boron delivery with liposomes for boron neutron capture therapy (BNCT): biodistribution studies in an experimental model of oral cancer demonstrating therapeutic potential.

Authors:  Elisa M Heber; Peter J Kueffer; Mark W Lee; M Frederick Hawthorne; Marcela A Garabalino; Ana J Molinari; David W Nigg; William Bauer; Andrea Monti Hughes; Emiliano C C Pozzi; Verónica A Trivillin; Amanda E Schwint
Journal:  Radiat Environ Biophys       Date:  2012-01-21       Impact factor: 1.925

2.  Boronated unnatural cyclic amino acids as potential delivery agents for neutron capture therapy.

Authors:  George W Kabalka; Aarif L Shaikh; Rolf F Barth; Tianyao Huo; Weilian Yang; Pamela M Gordnier; Subhash Chandra
Journal:  Appl Radiat Isot       Date:  2011-03-31       Impact factor: 1.513

3.  Therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes for oral cancer in the hamster cheek pouch model.

Authors:  Elisa M Heber; M Frederick Hawthorne; Peter J Kueffer; Marcela A Garabalino; Silvia I Thorp; Emiliano C C Pozzi; Andrea Monti Hughes; Charles A Maitz; Satish S Jalisatgi; David W Nigg; Paula Curotto; Verónica A Trivillin; Amanda E Schwint
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-27       Impact factor: 11.205

4.  Synthesis of α-carboranyl-α-acyloxy-amides as potential BNCT agents.

Authors:  Subash C Jonnalagadda; Jonathan S Cruz; Ryan J Connell; Patricia M Scott; Venkatram R Mereddy
Journal:  Tetrahedron Lett       Date:  2009-07-29       Impact factor: 2.415

5.  Biological evaluation of boronated unnatural amino acids as new boron carriers.

Authors:  G W Kabalka; M-L Yao; S R Marepally; S Chandra
Journal:  Appl Radiat Isot       Date:  2009-04-02       Impact factor: 1.513

Review 6.  Boron neutron capture therapy for malignant brain tumors.

Authors:  Shin-Ichi Miyatake; Masahiko Wanibuchi; Naonori Hu; Koji Ono
Journal:  J Neurooncol       Date:  2020-07-16       Impact factor: 4.130

7.  In Vitro and In Vivo Evaluation of Fluorescently Labeled Borocaptate-Containing Liposomes.

Authors:  Vladimir Kanygin; Alexander Zaboronok; Iuliia Taskaeva; Evgenii Zavjalov; Rinat Mukhamadiyarov; Aleksandr Kichigin; Anna Kasatova; Ivan Razumov; Roman Sibirtsev; Bryan J Mathis
Journal:  J Fluoresc       Date:  2020-10-19       Impact factor: 2.217

8.  Hemorrhage in mouse tumors induced by dodecaborate cluster lipids intended for boron neutron capture therapy.

Authors:  Tanja Schaffran; Nan Jiang; Markus Bergmann; Ekkehard Küstermann; Regine Süss; Rolf Schubert; Franz M Wagner; Doaa Awad; Detlef Gabel
Journal:  Int J Nanomedicine       Date:  2014-07-29

Review 9.  Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.

Authors:  Rolf F Barth; M Graca H Vicente; Otto K Harling; W S Kiger; Kent J Riley; Peter J Binns; Franz M Wagner; Minoru Suzuki; Teruhito Aihara; Itsuro Kato; Shinji Kawabata
Journal:  Radiat Oncol       Date:  2012-08-29       Impact factor: 3.481

Review 10.  Boron Neutron Capture Therapy for Malignant Brain Tumors.

Authors:  Shin-Ichi Miyatake; Shinji Kawabata; Ryo Hiramatsu; Toshihiko Kuroiwa; Minoru Suzuki; Natsuko Kondo; Koji Ono
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-05-31       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.